The overall objective of the Administrative Core is to oversee and coordinate the operations of the Center's activities and foster productive interactions and scientific synergy among the projects and cores within the Center. Additionally, the Administrative Core will coordinate and schedule interactions between the Center and our Community Advisory Council, external organizations such as the California Department of Developmental Services and our External Advisory Board (EAB). The following Objectives encompass the five areas of administrative responsibility: 1). Oversee and coordinate Center activities;2). Facilitate data and resource sharing;3). Provide budgetary oversight and grants management;4). Administer the Center's IRB and liaise with the MARBLES and CHARGE studies for the transfer of samples and data;and 5). Foster interactions and synergy among projects and cores within the Center. Considering the overall complexity of the Center's multidisciplinary approach, the goals of the Administrative Core are designed to provide a central office from which all business, scheduling, and organizational matters can be coordinated, and to facilitate the scientific collaborations among projects and cores that make the CCEH truly interdisciplinary. The Director and Deputy Director, along with the Executive Committee of Program Leaders, provide the day to- day leadership of the CCEH. The EAB provides long-term guidance on scientific and organizational matters. The Administrative Core has established a Community Outreach and Translation Core (COTC) Liaison that will coordinate our administrative efforts with those of our COTC. The COTC contact person (Rose) for the COTC Liaison (Hansen) will relay information regarding matters of public outreach, information exchange, and clinical translation between the two units to assure that these activities are coordinated and that the Director is aware of progress and any problems.
The Administration Core will oversee all aspects of the CCEH to ensure that the overarching theme of the center investigating the molecular and cellular mechanisms by which gene X environment interactions promote neurodevelopmental impairments relevant to autism is successful.
|Fritsch, Erika B; Stegeman, John J; Goldstone, Jared V et al. (2015) Expression and function of ryanodine receptor related pathways in PCB tolerant Atlantic killifish (Fundulus heteroclitus) from New Bedford Harbor, MA, USA. Aquat Toxicol 159:156-66|
|Walker, Cheryl K; Krakowiak, Paula; Baker, Alice et al. (2015) Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay. JAMA Pediatr 169:154-62|
|Harrington, Rebecca A; Lee, Li-Ching; Crum, Rosa M et al. (2014) Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics 133:e1241-8|
|Keil, Alexander P; Daniels, Julie L; Hertz-Picciotto, Irva (2014) Autism spectrum disorder, flea and tick medication, and adjustments for exposure misclassification: the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Environ Health 13:3|
|Shelton, Janie F; Geraghty, Estella M; Tancredi, Daniel J et al. (2014) Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the CHARGE study. Environ Health Perspect 122:1103-9|
|Piras, I S; Haapanen, L; Napolioni, V et al. (2014) Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with Autism Spectrum Disorder. Brain Behav Immun 38:91-9|
|Cao, Zhengyu; Cui, Yanjun; Nguyen, Hai M et al. (2014) Nanomolar bifenthrin alters synchronous Ca2+ oscillations and cortical neuron development independent of sodium channel activity. Mol Pharmacol 85:630-9|
|Medici, Valentina; Shibata, Noreene M; Kharbanda, Kusum K et al. (2014) Maternal choline modifies fetal liver copper, gene expression, DNA methylation, and neonatal growth in the tx-j mouse model of Wilson disease. Epigenetics 9:286-96|
|Akins, Roger S; Krakowiak, Paula; Angkustsiri, Kathleen et al. (2014) Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study. J Dev Behav Pediatr 35:1-10|
|Pretto, Dalyir I; Kumar, Madhur; Cao, Zhengyu et al. (2014) Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome. Neurobiol Aging 35:1189-97|
Showing the most recent 10 out of 204 publications